# RNN 1st Gen Model Cerner Corporation Computer integrated systems design

Stock predictor AI models:
Subscribe >> Deal exit on
May 3, 2018
Deal entry on
May 3, 2018
1.59%Expected margin
68.66% successful of 67 deals
$ 70.12 Last close price
at 18-oct-2021


Model's trade recommendations 13.65% Return for period

-2.00% Annual return

$19.22B Market Cap

β 0.96  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 13.65%
52wk return 5.87%
52wk Range
Sortino ratio -0.11
Sharpe ratio -0.09
Norm. RMSE 0.69%
Downside risk 11.57%
Volatility 0.00%
  • BUY Analysts consensus recommendation

Cerner Corporation's health information technologies connect people, information and systems provider facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs. Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities.

Industry sector: Medical

Sector classification: Computer integrated systems design

Deep Learning based analysis and prediction model for Cerner Corporation (CERN) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CERN model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for CERN.

Model is being retrained on a daily basis.

Float 316M
P/E 26.70
Shares Outstanding 332M
% Held by Insiders 4.71%
% Held by Institutions 78.90%
EPS (last reported FY) $2.20
EPS (last reported Q) $0.51
EPS, estimated (last reported Q) $0.53
Total revenues $5 B
Net income $1 B